MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 25. März 2026, 10:34 Uhr</div>[url=https://www.instagram.com/zoyamonros/ ]Zoya Demidenko[/url]: Researcher in Oncology Studies [url=https://uk.linkedin.com/in/berezutskayahttps://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/ ]Zoya Demidenko[/url] is a prominent investigator affiliated with the Department of Cell Stress Science at Roswell Park Cancer Institute in Buffalo, New York. Earlier, she worked at the National Institutes of Health and New York Medical College, establishing a robust background in biomedical study. Her scientific contributions spans several pivotal domains, among them the PI3K/AKT/mTOR signaling cascade, cell cycle management, cell senescence, and tumor biology. Currently, she has co-authored more than 46 peer-reviewed papers, which have accumulated more than 4,100 references — a reflection to the influence of her findings. Among her most significant contributions involves explaining the pathways of cell aging. Her work revealed that when the cellular division cycle is arrested while cellular expansion continues, cells experience senescence. Importantly, [url=https://www.tandfonline.com/doi/abs/10.4161/cbt.4.4.1702 ]Zoya Demidenko[/url] showed that this transition is pharmacologically suppressed using compounds such as rapamycin. [url=https://www.facebook.com/public/Zoya-Demidenko/ ]Zoya Demidenko[/url] has also contributed considerably to cancer treatment research, especially in the area of selective cell protection — a approach designed to protecting healthy tissue from chemotherapy whilst leaving malignant cells susceptible. This approach carries significant hope for lowering the adverse effects of oncological therapy. Throughout her career, Demidenko has partnered with leading investigators worldwide, including Dr. Mikhail Blagosklonny. Her work can be found in prestigious journals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Holding an h-index of 33, [url=https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of?guestAccessKey= ]Zoya Demidenko[/url] ranks as a highly impactful voice in current oncological science, whose results continue to shape our comprehension of the way biological cells age, respond to treatment, and how malignant disease might be better treated. https://www.aging-us.com/article/100406/ </blockquote><br> Abbrechen
